Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism sGC stimulants(Soluble guanylate cyclase stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22F2N6O3 |
InChIKeyOREKZCCNTFVURN-SZNDQCEHSA-N |
CAS Registry1628730-55-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | US | 01 May 2021 |